CC-101 (f/k/a NR1) Neural Stem Cell Transplantation for Adults With Chronic Ischemic Stroke
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Tacrolimus
Related studies linked through entity extraction aliases.
Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell Transplant
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- PHASE2
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE1
Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Randomized Controlled Trial Comparing the Effectiveness and Safety of Topical Tacrolimus 0.03% Versus Crisaborole 2% in Patients With Mild to Moderate Atopic Dermatitis Over 8 Weeks
- Status
- NOT_YET_RECRUITING
- Phase
- NA
MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE2
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
- Status
- RECRUITING
- Phase
- PHASE1
Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE2
Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
- Status
- RECRUITING
- Phase
- PHASE2
Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies
- Status
- RECRUITING
- Phase
- PHASE2
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
- Status
- RECRUITING
- Phase
- PHASE2
Rituximab and Targeted Nursing for Pediatric Nephrotic Syndrome
- Status
- COMPLETED
- Phase
- NA
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE1